Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000525201 | SCV000632577 | likely benign | Renal carnitine transport defect | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000525201 | SCV001317231 | uncertain significance | Renal carnitine transport defect | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Genome- |
RCV000525201 | SCV002055760 | likely benign | Renal carnitine transport defect | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Giacomini Lab, |
RCV000525201 | SCV002576618 | likely benign | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research | |
Natera, |
RCV002226472 | SCV002078331 | benign | Decreased circulating carnitine concentration | 2019-12-13 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000525201 | SCV002107453 | benign | Renal carnitine transport defect | 2019-12-13 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003935418 | SCV004748534 | likely benign | SLC22A5-related disorder | 2020-02-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |